Literature DB >> 815811

In vivo cytogenetic activity of sulphonylurea drugs in man.

W A Watson, J C Petrie, D B Galloway, I Bullock, J C Gilbert.   

Abstract

A cytogenetic investigation of diabetic patients undergoing treatment with sulphonylurea drugs, particularly chlorpropamide, shows that significantly more chromatid aberrations and chromosome exchange aberrations are present in the lymphocytes of these patients compared with controls. This is taken as evidence of possible mutagenic activity by these drugs, although the possibility cannot be ruled out that the diabetic state itself is a contributory factor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 815811     DOI: 10.1016/0165-1161(76)90080-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

Review 1.  Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Stowers; L J Borthwick
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

2.  Some aspects of the genetics and etiology of spontaneous diabetes mellitus.

Authors:  E Pimentel
Journal:  Acta Diabetol Lat       Date:  1979 Jul-Sep

Review 3.  Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.

Authors:  E Gebhart
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Increased single strand breaks in DNA of lymphocytes from diabetic subjects.

Authors:  M Lorenzi; D F Montisano; S Toledo; H C Wong
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.